New drug therapy approval report for 2019
Impact Innovation Predictability Access
This report, published by the Food and Drug Administration's Center for Drug Evaluation and Research, presents the most important key figures on the approval of new drug therapies in the United States through 2019.
Yes, let me download!
...and make my research life easier.
More than 7,500
companies trust
Statista
companies trust
Statista
Google
Samsung
Unilever
Procter and Gamble
Telekom
PayPal
Recommended studies and dossiers
- GlaxoSmithKline Pharmaceuticals Limited IndiaGlaxoSmithKline Pharmaceuticals Limited India
- New drug approval report for the US 2019New drug approval report for the US 2019
- Cell and gene therapyCell and gene therapy
- Pharmaceutical industry in IndiaPharmaceutical industry in India
- Regeneron 's financial results 2019Regeneron 's financial results 2019
- U.S. pharmaceutical industryU.S. pharmaceutical industry
- Global cell and gene therapy market overview 2020Global cell and gene therapy market overview 2020
- Bausch Health financial key figures 2019Bausch Health financial key figures 2019
- The Regulation of Medical Devices by the FDA 2016The Regulation of Medical Devices by the FDA 2016
- U.S. market for physical therapy 2014U.S. market for physical therapy 2014
- Health and diet survey for the US 2014Health and diet survey for the US 2014
- Biotech drug industryBiotech drug industry
- Generics and biosimilars in ItalyGenerics and biosimilars in Italy
- Health and food supplements in ItalyHealth and food supplements in Italy
- Pharmacies in ItalyPharmacies in Italy
- Pharmaceutical industry in Scandinavia Pharmaceutical industry in Scandinavia
- Pharmaceutical industry in BrazilPharmaceutical industry in Brazil
- Physical health in BelgiumPhysical health in Belgium
- Australian medtech and pharma industry outlook 2017Australian medtech and pharma industry outlook 2017
- MedImpact report on leading drugs U.S. 2018MedImpact report on leading drugs U.S. 2018
- Pharmaceutical industry in the United Kingdom (UK)Pharmaceutical industry in the United Kingdom (UK)
- Pharmaceutical market in ItalyPharmaceutical market in Italy
- Pharmaceutical industry in JapanPharmaceutical industry in Japan
- Pharmaceutical industry in the NetherlandsPharmaceutical industry in the Netherlands
- Johnson & JohnsonJohnson & Johnson
Show more
Recent studies and dossiers
- Numeri e indici dell'automedicazione 2020Numeri e indici dell'automedicazione 2020
- Health and food supplements in ItalyHealth and food supplements in Italy
- Generics and biosimilars in ItalyGenerics and biosimilars in Italy
You may also be interested in...
- FDA on breakthrough therapy requests by status 2019FDA on breakthrough therapy requests by status 2019
- Expedited drug approvals by firms from California 2014-2019Expedited drug approvals by firms from California 2014-2019
- FDA on breakthrough therapy requests granted by therapy area 2019FDA on breakthrough therapy requests granted by therapy area 2019
- FDA on breakthrough therapy requests by therapy area 2019FDA on breakthrough therapy requests by therapy area 2019
- Key measurements of U.S. CDER drug approvals in 2019Key measurements of U.S. CDER drug approvals in 2019
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron about Statista CEO, MindShare Germany
Any more questions?
Get in touch with us quickly and easily.
We are happy to help!
Contact

Contact (Europe)

Lodovica Biagi
Director of Operations
eu.support@statista.com
+44 (0)20 8189 7000
Mon - Fri, 9:30am - 5pm, GMT
New
All Dossiers for free within the Project Account
Order a Project Account now to get immediate access to our dossiers, studies and reports.
Statista Project Account
- Immediate access to dossiers, reports and studies
- Unlimited access to statistics, Market Outlooks and forecasts
- No subscription (30 days duration)